Results 141 to 150 of about 38,154 (222)

Factor Xa Inhibitor

Japanese Journal of Thrombosis and Hemostasis, 2003
Takashi KOIZUMI, Masahiko UCHIDA
openaire   +2 more sources

Efficacy and safety of bortezomib with dexamethasone regimen in elderly newly diagnosed multiple myeloma patients with co-morbidities [PDF]

, 2016
Bortezomib-based induction therapies have shown to increase complete response rates and are used as an upfront therapy for newly diagnosed multiple myeloma patients.
Lee, Saem
core   +1 more source

Clinical utility of rivaroxaban in stroke prevention associated with nonvalvular atrial fibrillation – patient considerations

Journal of Blood Medicine, 2014
Ingo Ahrens, Christoph Bode Heart Center, University of Freiburg, Department of Cardiology and Angiology I, Freiburg, Germany Abstract: The direct factor Xa inhibitor rivaroxaban was the first within the group of orally available direct factor Xa ...
Ahrens I, Bode C
doaj  

Peak and Trough Concentration Ranges of Factor Xa Inhibitors for Preventing Thromboembolic Stroke in Korean Patients with Non-valvular Atrial Fibrillation. [PDF]

Ann Lab Med
Park JS, Lim KH, Kim DH, Lee KM, Woo KS, Han JY.   +5 more
europepmc   +1 more source

Platelet-rich fibrin ensures hemostasis after single-tooth removal under factor Xa inhibitors - a clinical prospective randomized split-mouth study. [PDF]

Clin Oral Investig, 2023
Kyyak S, Jari A, Heimes D, Heider J, Kämmerer PW.   +4 more
europepmc   +1 more source

Impact of Factor Xa inhibitors on cardiovascular events in older patients with nonvalvular atrial fibrillation. [PDF]

Aging (Albany NY)
Takahashi M, Morimoto T, Tsushima R, Sudo Y, Sakamoto A, Sogo M, Ozaki M, Okawa K.   +7 more
europepmc   +1 more source

Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis. [PDF]

Cochrane Database Syst Rev, 2023
Wang X, Ma Y, Hui X, Li M, Li J, Tian J, Wang Q, Yan P, Li J, Xie P, Yang K, Yao L.   +11 more
europepmc   +1 more source

Endovascular Stenting and Factor Xa Inhibitors for Filter-Associated Chronic IVC Occlusion: A Case Series. [PDF]

Am J Case Rep
Cao P, Luo X, Gao R, Li Y, Li L, Zhang Y, Liu X.   +6 more
europepmc   +1 more source

The efficacy and safety of direct factor Xa inhibitors versus vitamin K antagonists for atrial fibrillation in patients on hemodialysis: a meta-analysis of randomized controlled trials. [PDF]

Proc (Bayl Univ Med Cent), 2023
Abuelazm M, Mahmoud A, Ali S, Gamal M, Elmezayen A, A Elzeftawy M, Abdelazeem B.   +6 more
europepmc   +1 more source

Adverse Events of Factor Xa Inhibitors in Pediatric Patients: A Meta-analysis and Pharmacovigilance Study. [PDF]

Paediatr Drugs
Chong S, Sun L, Mu G, Hua M, Xiang Q, Cui Y.   +5 more
europepmc   +1 more source